First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer

Title
First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer
Authors
Keywords
-
Journal
NEW ENGLAND JOURNAL OF MEDICINE
Volume 376, Issue 25, Pages 2415-2426
Publisher
New England Journal of Medicine (NEJM/MMS)
Online
2017-06-22
DOI
10.1056/nejmoa1613493

Ask authors/readers for more resources

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started